The prevalence and public health burden of chronic heart failure (CHF) in Europe is steadily
increasing mainly caused by the ageing population and prolonged survival of patients with …

Among various neuropsychiatric disorders, depression and anxiety are commonly
encountered in patients with heart failure (HF), reported in≥ 50% of patients attending a HF …

Objective The purpose of this systematic review and meta-analysis was to evaluate the
ability of psychosocial interventions to reduce depression and anxiety, improve quality of life …

Background Chronic heart failure (CHF) is a severe condition, often co-occurring with
depression and anxiety, that strongly affects the quality of life (QoL) in some patients …

BackgroundDespite the anticipated efficacy of escitalopram in treating depression and
anxiety in individuals with preexisting cardiovascular conditions, persistent concerns …

Different interventions have been evaluated for the treatment of depression in heart failure
(HF) patients. However, clear and established recommendations are lacking. PubMed …

Background Depression is an independent factor to predict the hospitalization and mortality
in the chronic HF patients. Citalopram is known as an effective drug for depression …

在综合医院里, 心血管疾病是一类发生率和致死率较高的疾病, 其风险因素和疾病预防一直是
人们研究的重点. 近年来, 因心理因素如抑郁焦虑对心血管疾病患者的重要影响 …

Background Depression and anxiety are more prevalent in patients with heart failure (HF)
than in the general population and reduce quality of life (QoL); therefore, clinical guidelines …

Cardiovascular disease (CVD) has high incidence and fatality rate in general hospitals, and
its risk factors and disease prevention have been the focus of research. In recent years …